JULIE BOOKER: Open Payments
NPI 1962659037 · LEWISTON, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 21 payments from 13 companies in 2025. Trend: 2023 $418 · 2024 $799 · 2025 $697
Food & beverage: $697
| Company | Payments | Amount |
|---|---|---|
| Pharmacosmos Therapeutics Inc. | 2 | $233 |
| AstraZeneca Pharmaceuticals LP | 5 | $129 |
| ABBVIE INC. | 3 | $85 |
| Syndax Pharmaceuticals, Inc. | 2 | $44 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $32 |
| Novocure Inc. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $22 |
| Amgen Inc. | 1 | $21 |
Products named: MONOFERRIC, LYNPARZA, EPKINLY, PYLARIFY, IMFINZI, Optune Gio, OJJAARA, NINLARO.
Industry payments across ME — which companies pay providers there.
